Type of initial antidiabetic agent, and SMBG were significant predictors of prescription costs. SMBG represent a major proportion of total costs; however, its use in combination with antidiabetic agents that do not cause hypoglycaemia is questionable (Diabetes Research and Clinical Practice)
Diabetes News
Category: Audits
Standards of Medical Care in Diabetes 2016
This position statement provides key clinical practice recommendations (American Diabetes Association)
Health economic burden that wounds impose on the National Health Service in the UK
Nutritional deficiency and diabetes were independent risk factors for non-healing (BMJ)
National Pregnancy in Diabetes Audit Report, 2014
England, Wales and the Isle of Man (HQIP)
Glycemic control in inpatients with diabetes following august changeover of trainee doctors in England
Contrary to expectations, inpatient glycemic control did not worsen in the first 4 weeks after changeover compared to the preceding 4 weeks before changeover in the 3-year period (Journal of Hospital Medicine)
The management of adult diabetes services in the NHS: progress review
Progress has been made to reduce the additional risk of death for people with diabetes. However, 22,000 are still estimated to be dying each year from diabetes related causes (National Audit Office)
Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012
Between 1988-1994 and 2011-2012, the prevalence of diabetes increased in the overall population and in all subgroups evaluated (JAMA)
National survey of the management of Diabetic Ketoacidosis (DKA) in the UK in 2014
Despite widespread adoption of national guidance, several areas of management of DKA are suboptimal, being associated with avoidable biochemical and clinical risk (Diabetic Medicine)
Prescribing for Diabetes
Prescribing for Diabetes in England 2005/06 to 2014/15, reports on prescribing trends on medicines prescribed in primary care in England for the treatment of diabetes and examines trends during the period April 2005 to March 2015 (Health and Social Care Information Centre)
The revised NICE draft guideline for type 2 diabetes: still a long way to go
Some positive changes have been made since the first draft was published in January, 2015, especially with respect to patient preferences. However, we believe that the revised guideline remains unfit for purpose and is a missed opportunity to improve the lives of patients with type 2 diabetes (Lancet)
Policy evaluation in diabetes prevention and treatment using a population-based macro simulation model: the MICADO model
Validation by comparison with independent empirical data showed that the MICADO model simulates the natural course of diabetes and its micro- and macrovascular complications well (Diabetic Medicine)
A decade in diabetes specialist services, 2000 to 2011, in England: the views of consultant diabetologists and diabetes specialist nurses amidst persistent healthcare delivery change
A willingness to innovate and work differently to improve services was identified; however, clinicians must be supported through organizational changes to ensure people with diabetes receive high-quality care. The disruptive nature of organizational change was a recurrent theme throughout the decade (Diabetic Medicine)
Is the current standard of care leading to cost-effective outcomes for patients with type 2 diabetes requiring insulin? a long-term health economic analysis for the UK
Although associated with improved clinical outcomes, insulin intensification as practiced in the UK has a relatively high cost per QALY and may not lead to cost-effective outcomes for patients with type 2 diabetes as currently defined by UK cost-effectiveness thresholds (Diabetes Research and Clinical Practice)
UK service level audit of insulin pump therapy in paediatrics
The number of children and young people on continuous subcutaneous insulin infusion therapy is consistent with numbers estimated by NICE. There is a worrying lack of funded healthcare professional time. The audit also identified gaps in the provision of structured education and absence of written inpatient guidelines (Diabetic Medicine)
Inequality in Diabetes-Related Hospital Admissions in England by Socioeconomic Deprivation and Ethnicity
More deprived areas had higher rates of inpatient admissions and readmissions due to diabetes (PLoS ONE)
National Paediatric Diabetes Audit
National Paediatric Diabetes Audit Annual Report, covering 2013-14 (Royal College of Paediatrics and Child Health)
Taking Control: Supporting people to self-manage their diabetes
Examines in detail why many individuals are not getting the support they need to self-manage their diabetes and what the NHS, clinical commissioning groups, healthcare professionals and providers can do to address this (All-Party Parliamentary Group for Diabetes)
Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-randomized controlled trial
Given conventional thresholds of cost-effectiveness, the intensive treatment delivered in ADDITION was not cost-effective compared with routine care for individuals with screen-detected diabetes in the UK. The intervention may be cost-effective if it can be delivered at reduced cost (Diabetic Medicine)
Estimating Cost-Effectiveness in Type 2 Diabetes
A marked difference in treatment cost-effectiveness was demonstrated when comparing routine clinical practice with guideline-advocated therapy escalation. This is important to both health care professionals and the wider health economic community with respect to understanding the true cost-effectiveness profile of any particular T2DM therapy option (Medical Decision Making)
Together for Health – A Diabetes Delivery Plan
A Delivery Plan up to 2016 for NHS Wales and its partners
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- Next Page »
Glycosmedia is also available as an App: